Hepatitis C elimination in Myanmar: Modelling the impact, cost, cost-effectiveness and economic benefits

• Main Authors: Nick Scott (Author), Thin Mar Win (Author), Tom Tidhar (Author), Hla Htay (Author), Bridget Draper (Author), Phyo Thu Zar Aung (Author), Yinzong Xiao (Author), Anna Bowring (Author), Christian Kuschel (Author), Sonjelle Shilton (Author), Khin Pyone Kyi (Author), Win Naing (Author), Khin Sanda Aung (Author), Margaret Hellard (Author)
• Format: Book
• Published: Elsevier, 2021-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Myanmar has set national hepatitis C (HCV) targets to achieve 50% of people diagnosed and 50% treated by 2030. The WHO has additional targets of reducing incidence by 80% and mortality by 65% by 2030. We aimed to estimate the impact, cost, cost-effectiveness and net economic benefit of a...